Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/4/18 → 4/4/21 |
Funding
- PPD Investigator Services, LLC ((OE) Prot #GSK 204862 // (OE) Prot #GSK 204862)
- GlaxoSmithKline LLC ((OE) Prot #GSK 204862 // (OE) Prot #GSK 204862)
Prot #GSK 204862: TANGO: A Phase III, Randomized, Multicenter, Parallel-Group, Non-Inferiority Study Evaluating the Efficacy, safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
- Taiwo, Babafemi O (PD/PI)
Project: Research project